Ipsen Celebrates Opening of New Cambridge Headquarters with Day of Service
June 20 2019 - 04:00PM
Business Wire
– Ipsen officially opens North American
headquarters at One Main Street and recently renovated R&D and
Global External Innovation and Partnering facilities at 650 East
Kendall Street –
– More than 115 employees join together to
support nine local non-profit organizations –
Ipsen Biopharmaceuticals, an affiliate of Ipsen (Euronext: IPN;
ADR: IPSEY), today celebrated the grand opening of the company’s
new North American headquarters in Cambridge, Mass. As part of the
festivities, more than 115 Ipsen employees took to the community
for a Day of Service, supporting and volunteering for nine local
charities and non-profit organizations.
“At Ipsen, our dedicated employees strive every day to help
improve the lives of the patients we serve. We’re honored and
thankful for their commitment to making a difference, and to having
a positive impact on the communities in which we live and work,”
said Richard Paulson, CEO of Ipsen North America. “Today is about
more than marking the opening of our new Kendall Square
headquarters – it’s about teamwork and giving back, and we’re proud
to be here to participate.”
Ipsen’s Day of Service was coordinated with the help of Life
Science Cares, an organization dedicated to eliminating poverty in
the greater Boston area. Activities ranged from making updates and
repairs to old buildings to cooking meals for families in need, and
sorting and packaging clothing donations to prepare them for
distribution. Participating organizations included:
- Boston Healthcare for the Homeless Program (BHCHP)
- Cambridge and Somerville Programs for Addiction Recovery
(CASPAR)
- Cradles to Crayons Brighton
- Dimock Center Roxbury
- VA Boston Fisher House
- Breakthrough Greater Boston
- Message of Hope Foundation
- More Than Words Waltham
- Year Up Greater Boston
Ipsen announced the relocation of its North American
headquarters from Basking Ridge, NJ to Cambridge in June 2018. With
the move, the company co-located its Commercial business with its
Research & Development, Manufacturing, and Global External
Innovation and Partnering teams already based in Kendall Square –
creating a fully integrated biopharmaceutical business in the
United States. There are currently more than 290 employees in
Kendall Square, with continued growth planned with the addition of
more than 50 roles in 2019.
“This strategic move allows Ipsen to further capitalize on –
and, importantly, invest in – the area’s robust biotech ecosystem
to support our company’s accelerated growth, as well as leverage
key industry partnerships and major academic prowess in the area,”
added Paulson. “It also provides access to top talent, and an
opportunity to raise our profile and visibility as an employer of
choice.”
Today’s grand opening includes celebration of Ipsen’s new
50,000-square-foot headquarters at One Main Street and the
company’s recently renovated 46,000-square-foot facility at 650
East Kendall Street, home of Ipsen’s R&D and Global External
Innovation and Partnering teams, as well as the Ipsen Innovation
Center – Biolabs, a 15,000-square-foot life science co-working
facility dedicated to supporting entrepreneurs and startup
companies developing the next generation of therapeutics for
patients. Ipsen also has a manufacturing facility located at One
Kendall Square.
Follow #WeAreIpsen on Twitter and LinkedIn to see Ipsen’s Day of
Service in action and learn more about the company’s dedication to
the greater Cambridge/Boston communities.
ABOUT IPSEN IN NORTH AMERICA Ipsen (Euronext: IPN; ADR:
IPSEY) is a global biopharmaceutical company focused on innovation
and specialty care. The company develops and commercializes
innovative medicines in three key therapeutic areas – Oncology,
Neuroscience and Rare Diseases. At Ipsen, we focus our resources,
investments and energy on discovering, developing and
commercializing new therapeutic options to provide hope for
patients whose lives are challenged by difficult-to-treat diseases.
Ipsen’s North American operations are located in Cambridge,
Massachusetts, one of the company’s three global hubs. Based in the
heart of Kendall Square, our fully integrated biopharmaceutical
business includes Commercial, Research & Development,
Manufacturing, and Global External Innovation and Partnering.
Combined with our Canadian headquarters in Mississauga, Ontario,
and other locations, Ipsen employs approximately 600 people in
North America. For more information please visit www.ipsenus.com or
www.ipsen.ca. Connect with us on Twitter and LinkedIn.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20190620005598/en/
Elliot Fox +1.212.257.6724 efox@w2ogroup.com
Ipsen (EU:IPN)
Historical Stock Chart
From Feb 2024 to Mar 2024
Ipsen (EU:IPN)
Historical Stock Chart
From Mar 2023 to Mar 2024